PalEndo
Friends....don't let Endo/Paladin distract you......it is a completely unrelated activity between two companies....granted they both have BNC ties, but it is only coincidence to be sure....
The only question you need to ask yourself about whether Endo is making this play for Paladin for a proxy shot at BNC is this.......why would Endo have spent tens of millions if not some hundreds of millions on a PIIIb trial that would be nearing completion, one that was pivotal and would support FDA application in the near term....to only walk away with essentially nothing......do you think they would spend that money to then spend more to acquire our most recent loan shark to get access to something they already had???? We may be used to businesses being run like asylums, you can be sure that Endo is not that.....
The Paladin/Endo announcement comes at an opportune time for our BNC mgmt friends in that it is having the precise effect they would like..that is, as another totally unrelated topic that has nothing to do with the here and now and what is most important to BNC shareholders.....I want to know when/if AH is getting sold...when my divy is coming....are we keeping Sin Susto rights? Is the cash inferno VMC being sold/shuttered as I can't see pouring more dollars into a facility that produces product for a business line we will not own in 6 months or less (remember the reason for stopping GMP was to provide cost savings to producing in-house an AH product.....) What about Immuno/Oncocidin?? Keeping royalties on them??
So many other things of real importance to ask and hold our distinguished mgmt and BoD team reasonable for.....the last thing I care about is the Endo/Paladin effect.......no one in current or former mgmt had the wherewithall to devise a conspiracy of this magnitude and to think otherwise only feeds a misplaced megalomania.....